يعرض 1 - 10 نتائج من 3,343 نتيجة بحث عن '"Epoetin Alfa"', وقت الاستعلام: 1.39s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية

    المصدر: Meditsinskiy sovet = Medical Council; № 11 (2023); 90-99 ; Медицинский Совет; № 11 (2023); 90-99 ; 2658-5790 ; 2079-701X

    وصف الملف: application/pdf

    العلاقة: https://www.med-sovet.pro/jour/article/view/7624/6767Test; Roy C.N. Anemia of inflammation. Hematology Am Soc Hematol Educ Program. 2010;(1):276–280. https://doi.org/10.1182/asheducation-2010.1.276Test.; Madeddu C., Gramignano G., Astara G., Demontis R., Sanna E., Atzeni V., Macciò A. Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach. Front Physiol. 2018;9:1294. https://doi.org/10.3389/fphys.2018.01294Test.; Merlini L., Cartenì G., Iacobelli S., Stelitano C., Airoldi M., Balcke P. et al. Anemia prevalence and treatment practice in patients with non-myeloid tumors receiving chemotherapy. Cancer Manag Res. 2013;5:205–214. https://doi.org/10.2147/CMAR.S45236Test.; Naoum F.A. Iron deficiency in cancer patients. Rev Bras Hematol Hemoter. 2016;38(4):325–330. https://doi.org/10.1016/j.bjhh.2016.05.009Test.; Finberg K.E., Heeney M.M., Campagna D.R., Aydinok Y., Pearson H.A., Hartman K.R. et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nat Genet. 2008;40(5):569–571. https://doi.org/10.1038/ng.130Test.; Natalucci V., Virgili E., Calcagnoli F., Valli G., Agostini D., Zeppa S.D. et al. Cancer Related Anemia: An Integrated Multitarget Approach and Lifestyle Interventions. Nutrients. 2021;13(2):482. https://doi.org/10.3390/nu13020482Test.; Testa U. Recent developments in the understanding of iron metabolism. Hematol J. 2002;3(2):63–89. https://doi.org/10.1038/sj.thj.6200163Test.; Brugnara C., Schiller B., Moran J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin Lab Haematol. 2006;28(5):303–308. https://doi.org/10.1111/j.1365-2257.2006.00812.xTest.; Busti F., Marchi G., Ugolini S., Castagna A., Girelli D. Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy. Pharmaceuticals (Basel). 2018;11(4):94. https://doi.org/10.3390/ph11040094Test.; Ludwig H., Van Belle S., Barrett-Lee P., Birgegård G., Bokemeyer C., Gascón P. et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer. 2004;40(15):2293–2306. https://doi.org/10.1016/j.ejca.2004.06.019Test.; Thomas M.R., Scully M. How I treat microangiopathic hemolytic anemia in patients with cancer. Blood. 2021;137(10):1310–1317. https://doi.org/10.1182/blood.2019003810Test.; Birgegård G., Aapro M.S., Bokemeyer C., Dicato M., Drings P., Hornedo J. et al. Cancer-related anemia: pathogenesis, prevalence and treatment. Oncology. 2005;68(Suppl. 1):3–11. https://doi.org/10.1159/000083128Test.; Schwartz R.N. Anemia in patients with cancer: incidence, causes, impact, management, and use of treatment guidelines and protocols. Am J Health Syst Pharm. 2007;64(3 Suppl. 2):S5–S30. https://doi.org/10.2146/ajhp060601Test.; Crawford J., Cella D., Cleeland C.S., Cremieux P.Y., Demetri G.D., Sarokhan B.J. et al. Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer. 2002;95(4):888–895. https://doi.org/10.1002/cncr.10763Test.; Park C.H., Valore E.V., Waring A.J., Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276(11):7806–7810. https://doi.org/10.1074/jbc.M008922200Test.; Pigeon C., Ilyin G., Courselaud B., Leroyer P., Turlin B., Brissot P., Loréal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276(11):7811–7819. https://doi.org/10.1074/jbc.M008923200Test.; Weinstein D.A., Roy C.N., Fleming M.D., Loda M.F., Wolfsdorf J.I., Andrews N.C. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood. 2002;100(10):3776–3781. https://doi.org/10.1182/blood-2002-04-1260Test.; Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A., Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101(7):2461–2463. https://doi.org/10.1182/blood-2002-10-3235Test.; Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113(9):1271–1276. https://doi.org/10.1172/JCI20945Test.; Kader A.S., Lim J.T., Berthelet E., Petersen R., Ludgate D., Truong P.T. Prognostic significance of blood transfusions in patients with esophageal cancer treated with combined chemoradiotherapy. Am J Clin Oncol. 2007;30(5):492–497. https://doi.org/10.1097/01.coc.0000264177.66369.18Test.; Détivaud L., Nemeth E., Boudjema K., Turlin B., Troadec M.B., Leroyer P. et al. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood. 2005;106(2):746–748. https://doi.org/10.1182/blood-2004-12-4855Test.; Macciò A., Madeddu C., Massa D., Mudu M.C., Lusso M.R., Gramignano G. et al. Hemoglobin levels correlate with interleukin-6 levels in patients with advanced untreated epithelial ovarian cancer: role of inflammation in cancer-related anemia. Blood. 2005;106(1):362–367. https://doi.org/10.1182/blood-2005-01-0160Test.; Schaer D.J., Buehler P.W., Alayash A.I., Belcher J.D., Vercellotti G.M. Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood. 2013;121(8):1276–1284. https://doi.org/10.1182/blood-2012-11-451229Test.; Sasu B.J., Cooke K.S., Arvedson T.L., Plewa C., Ellison A.R., Sheng J. et al. Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. Blood. 2010;115(17):3616–3624. https://doi.org/10.1182/blood-2009-09-245977Test.; Baker R.D., Greer F.R. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0–3 years of age). Pediatrics. 2010;126(5):1040–1050. https://doi.org/10.1542/peds.2010-2576Test.; Rizzo J.D., Brouwers M., Hurley P., Seidenfeld J., Arcasoy M.O., Spivak J.L. et al. American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Clin Oncol. 2010;28(33):4996–5010. https://doi.org/10.1200/JCO.2010.29.2201Test.; Xu H., Xu L., Page J.H., Cannavale K., Sattayapiwat O., Rodriguez R., Chao C. Incidence of anemia in patients diagnosed with solid tumors receiving chemotherapy, 2010-2013. Clin Epidemiol. 2016;8:61–71. https://doi.org/10.2147/CLEP.S89480Test.; Gilreath J.A., Stenehjem D.D., Rodgers G.M. Diagnosis and treatment of cancer-related anemia. Am J Hematol. 2014;89(2):203–212. https://doi.org/10.1002/ajh.23628Test.; Hashemi S.M., Mashhadi M.A., Mohammadi M., Ebrahimi M., Allahyari A. Absolute and Functional Iron Deficiency Anemia among Different Tumors in Cancer Patients in South Part of Iran, 2014. Int J Hematol Oncol Stem Cell Res. 2017;11(3):192–198. Available at: https://pubmed.ncbi.nlm.nih.gov/28989585Test/; Estiri M., Estiri B., Fallah A., Aghazadeh M., Sedaqati A., Abdollahi A. et al. Therapeutic Effects of Mesenchymal Stem Cells Expressing Erythropoietin on Cancer-Related Anemia in Mice Model. Curr Gene Ther. 2022;22(5):406–416. https://doi.org/10.2174/1566523222666220405134136Test.; https://www.med-sovet.pro/jour/article/view/7624Test

  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية